28th September 2021 at 3pm BST
Bringing a new biotherapeutic to market is a multifaceted process. Ensuring safety, efficacy, and product quality is paramount. Biopharmaceuticals, by their nature, are highly complex.
Heterogeneity occurs naturally by biological modification or can be unwanted consequence of manufacturing and storage. Critical quality attributes affecting safety and efficacy need to be identified, characterized, controlled, and monitored throughout the drug discovery and development cycle. Analytical techniques that can characterize and quantify levels of biotherapeutic complexity are in high demand.
Join the conversation as a panel of Amgen experts discuss how analytical techniques evolved over the years to serve the needs of the industry, and what trends they observe which will increase productivity further.
Learning Objectives:
Why is analytical work so important for the discovery, development, and manufacture of new biologic drugs?
What analytical advances have had the biggest impact in terms of developing biologics?
How is Amgen adopting and evaluating new analytical techniques?
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
